STAT3 and gastric cancer: They performed pharmacologic inhibition (pervanadate) or knockdown of SHP-1 prior to pantoprazole treatment in order to validate the role of SHP-1 in the inhibition of STAT3 activity by pantoprazole in gastric cancer cells.